UnitedHealth raises outlook

- UnitedHealth posted a stronger-than-expected Q1 and raised its full-year outlook for 2026. - The company lifted full-year adjusted EPS guidance from above $17.75 to above $18.25, according to analyst reports. - Analysts responded by raising price targets, citing Medicare Advantage strength and favorable Optum Health trends. (investing.com)

UnitedHealth Group raised its 2026 profit outlook on April 21 after first-quarter results beat Wall Street estimates. (unitedhealthgroup.com) The company reported first-quarter revenue of $111.7 billion, up 2% from a year earlier, with earnings of $6.90 a share and adjusted earnings of $7.23 a share. UnitedHealth said full-year 2026 adjusted net earnings should top $18.25 a share, up from its earlier forecast of more than $17.75. (unitedhealthgroup.com) Reuters, in a report published by CNBC, said analysts had expected lower first-quarter profit and that UnitedHealth’s updated outlook reflected better control of medical costs and operational changes. CNBC reported the company is still working through a broader turnaround after a stretch of elevated care use and restructuring. (cnbc.com) UnitedHealth runs the country’s largest private health insurer through UnitedHealthcare and a large care-and-services business through Optum. Its outlook matters across the sector because Medicare Advantage margins and physician-clinic performance have been central questions for insurers since medical costs jumped in 2024 and 2025. (unitedhealthgroup.com) (cnbc.com) The company’s January outlook for 2026 called for revenue above $439 billion, a year-over-year decline tied to what it described as “right-sizing across the enterprise.” Tuesday’s report kept the focus on margin recovery rather than membership growth, with Investing.com noting management expects about two-thirds of first-half earnings to come from UnitedHealthcare and Optum Health. (cnbc.com) (investing.com) Analysts moved quickly after the report. Investing.com said Deutsche Bank raised its price target to $360 from $304 while keeping a Hold rating, and MarketScreener listed target increases from Jefferies to $373 from $340 and Piper Sandler to $403 from $399 on April 20 and April 21. (in.investing.com) (marketscreener.com) Benzinga also reported Oppenheimer raised its target to $405 from $385 after the quarter, while describing analyst views as mixed. That split reflects a stock still recovering from a steep selloff over the past year even after this week’s guidance increase. (benzinga.com) (investing.com) For now, the clearest change is numerical: UnitedHealth added at least 50 cents a share to its 2026 adjusted earnings target in April, and analysts responded by lifting price targets rather than cutting them. (unitedhealthgroup.com) (cnbc.com)

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.